In Silico Studies of M. Tuberculosis L-Lysine 6- Monooxygenase (Mbtg) As Potential Target and an Approach for Repurposing First Line Antitubercular Oral Drugs. J. Int. Acad. Phys. Sci. 2016, 20 (4), 325-335.